{
  "paper_metadata": {
    "pmid": "34287479",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted BRCA2 variant information and penetrance data from a study on postmenopausal breast cancer patients."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.2T>G",
      "protein_notation": "p.Met1Arg",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 49,
        "demographics": "postmenopausal women aged \u226555 years",
        "phenotype": "invasive ductal breast carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 5,
        "affected_count": 5,
        "unaffected_count": 0,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "invasive ductal breast carcinoma",
          "evidence_sentence": "Among 49 postmenopausal unrelated women, 5 (10.2%) were identified to harbor mutations of clinical significance, 3 in BRCA1 and 2 in BRCA2."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "invasive ductal breast carcinoma",
          "evidence_sentence": "Among 49 postmenopausal unrelated women, 5 (10.2%) were identified to harbor mutations of clinical significance, 3 in BRCA1 and 2 in BRCA2."
        }
      ],
      "functional_data": {
        "summary": "The mutations were identified through next-generation sequencing and Sanger sequencing.",
        "assays": [
          "Next-generation sequencing",
          "Sanger sequencing"
        ]
      },
      "segregation_data": "All five BRCA mutations were identified among 47 patients who reported a positive family history of breast, ovarian, prostate, and pancreatic cancers.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The presence of CHEK2 c.1100delC mutation was investigated in 47 out of the 49 patients; however, no mutations were detected.",
      "key_quotes": [
        "Among 49 postmenopausal unrelated women, 5 (10.2%) were identified to harbor mutations of clinical significance, 3 in BRCA1 and 2 in BRCA2."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.5645C>A",
      "protein_notation": "p.Gln1882*",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 49,
        "demographics": "postmenopausal women aged \u226555 years",
        "phenotype": "invasive ductal breast carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 5,
        "affected_count": 5,
        "unaffected_count": 0,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "invasive ductal breast carcinoma",
          "evidence_sentence": "Among 49 postmenopausal unrelated women, 5 (10.2%) were identified to harbor mutations of clinical significance, 3 in BRCA1 and 2 in BRCA2."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "invasive ductal breast carcinoma",
          "evidence_sentence": "Among 49 postmenopausal unrelated women, 5 (10.2%) were identified to harbor mutations of clinical significance, 3 in BRCA1 and 2 in BRCA2."
        }
      ],
      "functional_data": {
        "summary": "The mutations were identified through next-generation sequencing and Sanger sequencing.",
        "assays": [
          "Next-generation sequencing",
          "Sanger sequencing"
        ]
      },
      "segregation_data": "All five BRCA mutations were identified among 47 patients who reported a positive family history of breast, ovarian, prostate, and pancreatic cancers.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The presence of CHEK2 c.1100delC mutation was investigated in 47 out of the 49 patients; however, no mutations were detected.",
      "key_quotes": [
        "Among 49 postmenopausal unrelated women, 5 (10.2%) were identified to harbor mutations of clinical significance, 3 in BRCA1 and 2 in BRCA2."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 2",
      "table_caption": "BRCA1 and BRCA2 mutations identified in postmenopausal breast cancer patients.",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text and tables."
  }
}